Medovex Corporation Retains CG Capital As Investor Relations Counsel Post author:Sam Post published:April 13, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017 PPD Heroes Advocate For Clinical Research To Improve Patient Health April 19, 2017 FDA Sticks Breakthrough Tag on GlaxoSmithKline's Blood Cancer Drug November 1, 2017
Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017